Number and severity of adverse events using the current CTCAE version 4Ĭompare arm volume and mobility measurements between patients that received regional RT or notĬompare patient-reported outcomes (PROs) and the quality of life (QOL) between patients that received regional RT or notĬompare the quality of life (QOL) between patients that received regional RT or notĬompare the cost-effectiveness between patients that received regional RT or not These women may be exposed to the side effects of their treatment without benefit.Ĭompare the breast cancer recurrence-free interval (BCRFI) between patients that received regional RT or notĬompare the invasive disease-free survival between patients that received regional RT or not.Ĭompare the breast cancer mortality between patients that received regional RT or not.Ĭompare the overall survival (OS) between patients that received regional RT or notĬompare the locoregional recurrence-free interval (LRRFI) between patients that received regional RT or not.Ĭompare the distant recurrence-free interval (DRFI) between patients that received regional RT or not. Some women may be getting regional radiotherapy who do not need it. No one really knows whether patients with low risk breast cancer need to receive regional radiotherapy. Many women will also receive radiotherapy to the whole breast/chest area and the surrounding lymph glands (called regional radiotherapy). Women with node positive breast cancer normally will receive endocrine therapy and some may receive chemotherapy to help prevent the cancer from coming back.
0 kommentar(er)
